Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15717816rdf:typepubmed:Citationlld:pubmed
pubmed-article:15717816lifeskim:mentionsumls-concept:C0009170lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C1704686lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C0014499lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C0699784lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C0870071lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C0024828lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:15717816lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:15717816pubmed:issue4lld:pubmed
pubmed-article:15717816pubmed:dateCreated2005-2-18lld:pubmed
pubmed-article:15717816pubmed:abstractTextEveringham and Rydell's Markov chain model of cocaine demand is modified and updated in light of recent data. Key insights continue to hold, e.g., that the proportion of cocaine demand stemming from heavy vs. light users changed dramatically over the 1980s. New insights emerge, e.g., pertaining to the average duration of a career of heavy use (about 12 years) and the negative relationship between levels of heavy use and epidemic "infectivity" or the number of new initiates per current user per year. This illustrates how simple modeling can yield insights directly relevant to managing complex drug control policy questions.lld:pubmed
pubmed-article:15717816pubmed:languageenglld:pubmed
pubmed-article:15717816pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15717816pubmed:citationSubsetIMlld:pubmed
pubmed-article:15717816pubmed:statusMEDLINElld:pubmed
pubmed-article:15717816pubmed:monthNovlld:pubmed
pubmed-article:15717816pubmed:issn1386-9620lld:pubmed
pubmed-article:15717816pubmed:authorpubmed-author:CaulkinsJonat...lld:pubmed
pubmed-article:15717816pubmed:authorpubmed-author:KnollClaudiaClld:pubmed
pubmed-article:15717816pubmed:authorpubmed-author:BehrensDoris...lld:pubmed
pubmed-article:15717816pubmed:authorpubmed-author:TraglerGernot...lld:pubmed
pubmed-article:15717816pubmed:authorpubmed-author:ZubaDorisDlld:pubmed
pubmed-article:15717816pubmed:issnTypePrintlld:pubmed
pubmed-article:15717816pubmed:volume7lld:pubmed
pubmed-article:15717816pubmed:ownerNLMlld:pubmed
pubmed-article:15717816pubmed:authorsCompleteYlld:pubmed
pubmed-article:15717816pubmed:pagination319-29lld:pubmed
pubmed-article:15717816pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15717816pubmed:meshHeadingpubmed-meshheading:15717816...lld:pubmed
pubmed-article:15717816pubmed:meshHeadingpubmed-meshheading:15717816...lld:pubmed
pubmed-article:15717816pubmed:meshHeadingpubmed-meshheading:15717816...lld:pubmed
pubmed-article:15717816pubmed:meshHeadingpubmed-meshheading:15717816...lld:pubmed
pubmed-article:15717816pubmed:meshHeadingpubmed-meshheading:15717816...lld:pubmed
pubmed-article:15717816pubmed:year2004lld:pubmed
pubmed-article:15717816pubmed:articleTitleMarkov chain modeling of initiation and demand: the case of the U.S. cocaine epidemic.lld:pubmed
pubmed-article:15717816pubmed:affiliationCarnegie Mellon University, H. John Heinz III School of Public Policy Management, 5000 Forbes Ave., Pittsburgh, PA 15213, USA. caulkins@andrew.cmu.edulld:pubmed
pubmed-article:15717816pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15717816pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15717816lld:pubmed